Abcellera twitter sentiment
Twitter users discuss $ABCL as a generational company with fully integrated tech stack for antibody discovery, on verge of platform validation via ABCL635 Phase 2 efficacy readout in Q3 2026, plus two other molecules advancing to human studies; holding long--term at ~1.5B market cap with $650M liquidity.
Sources
- https://x.com/i/status/2060854612039487910
- https://x.com/i/status/2060848900848685301
- https://x.com/i/status/2060868191836926147
- https://x.com/i/status/2060854769216843860
- https://x.com/i/status/2060843505719611889
- https://x.com/i/status/2060835478589559136
- https://x.com/i/status/2060830238238740840
- https://x.com/i/status/2060859046911938670
- https://x.com/i/status/2060855190354285039
- https://x.com/i/status/2060837514001170454
- https://x.com/i/status/2060045937586983246
- https://x.com/i/status/2060846281778475473
- https://x.com/i/status/2060860087531426245
- https://x.com/i/status/2060855817134297116
- https://x.com/i/status/2060847623158788256
- https://x.com/i/status/2060838837165903922
- https://x.com/i/status/2060182301200220419
- https://x.com/i/status/2060401443082031574
- https://x.com/i/status/2060120911983059173
- https://x.com/i/status/2060379030444982447